Chronic Pain Clinical Trial
Official title:
Tai Chi Intervention for Geriatric Pain Syndrome
Verified date | November 2023 |
Source | University of Massachusetts, Boston |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
Accumulating evidence supports that more pain, whether measured by number of pain sites or pain severity, is associated with poorer cognitive function and mobility, and fall risk in older persons. Tai Chi which holistically integrates physical and cognitive functions offers the possibility not only of alleviating pain but also improving attention and mobility in the many older adults who have chronic multisite pain. This proposed full-size randomized controlled Tai Chi trial is a direct extension of our previous work examining chronic pain, attention demands, mobility and falls in the older population, and is built on the investigators' National Institute on Aging-supported Tai Chi feasibility and acceptability pilot study among older adults with multisite pain and risk for falls. The goal of this single-blinded randomized controlled trial is to examine the effects of a 24-week Tai Chi intervention on chronic pain, cognition, mobility, fear of falling, and rates of total and injurious falls in older adults with multisite pain and at risk for falls. The results of this study will provide a foundation to establish the clinical significance of Tai Chi in the management of chronic multisite pain and to explore the mechanisms through which Tai Chi improves chronic pain symptoms and lowers rates of total and injurious falls in at-risk older adults.
Status | Not yet recruiting |
Enrollment | 200 |
Est. completion date | March 31, 2029 |
Est. primary completion date | March 31, 2029 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 65 Years and older |
Eligibility | Inclusion Criteria: 1. Aged 65 years and older 2. have chronic multisite (2 or more sites) musculoskeletal pain (lasting 3 or more months in the previous year and present in the previous month) 3. reports at least 1 fall in the previous year or currently using an assistive device to walk (cane or walker) 4. Able to walk 20-feet without personal assistance 5. has never practiced Tai Chi or other mind-body exercise in the previous 5 years 6. able to communicate in English Exclusion Criteria: 1. Actively engaged in moderate to vigorous exercise for more than 40 minutes/ week 2. Have practiced Tai Chi or other mind-body exercise within the past year 3. Practiced Tai Chi or other mind-body exercise for 3 or more months in the past 5 years 4. Physician diagnosis of any condition that might interfere with study participation including the following: unstable cardiac disease, stroke, rheumatoid arthritis, degenerative neuromuscular diseases, Parkinson's disease, terminal disease, or dementing illness |
Country | Name | City | State |
---|---|---|---|
n/a |
Lead Sponsor | Collaborator |
---|---|
University of Massachusetts, Boston |
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Pain severity | Pain severity will be assessed using the Brief Pain Inventory. | 24 weeks | |
Primary | Pain interference | Pain interference will be assessed using the Brief Pain Inventory. | 24 weeks | |
Primary | Fear of falling | Fear of falling will be assessed using the Tinetti Falls Efficacy Scale. | 48 weeks | |
Primary | Rate of total falls | Rate of total falls will be assessed using monthly falls calendar postcards. | 48 weeks | |
Primary | Rate of injurious falls | Rate of injurious falls will be assessed using the Abbreviated Injury Scale. | 48 weeks | |
Secondary | Inflammatory markers | Plasma levels of C-reactive protein, interleukin 6, tumor necrosis factor alpha and Nuclear Factor kappa B will be measured using enzyme-linked immunosorbent assays. | 24 weeks | |
Secondary | Beta endorphin | Plasma levels of beta endorphin will be measured using an enzyme-linked immunosorbent assay. | 24 weeks | |
Secondary | Attention | Attention will be assessed by using 4 subscales of the Test of Everyday Attention. | 24 weeks | |
Secondary | Executive function | Executive function will be assessed using the Trailmaking test, which requires the connection of sequentially numbered circles (part A), and the connection of circles marked by numbers and letters in alternating sequence (part B). | 24 weeks | |
Secondary | Single-task gait | Gait will be assessed using a sensored gait mat that has embedded pressure sensors distributed throughout the mat. The mat measures location and timing of individual steps, which then can be used to calculate spatio-temporal gait parameters including our outcome measures of stride time, stride length, and swing time. | 24 weeks | |
Secondary | Dual-task gait | Gait will be assessed using a sensored gait mat that has embedded pressure sensors distributed throughout the mat. The mat measures location and timing of individual steps, which then can be used to calculate spatio-temporal gait parameters including our outcome measures of stride time, stride length, and swing time. During the dual task walking, the participants will perform 2 sets of cognitive challenges in random order: serial subtractions 3 and 5 from 100. Dual task performance and number of errors on the serial subtractions will be recorded. Coefficient of variation will be used as a measure of gait variability (SD/mean x 100). The dual task decrement, the difference between single task and dual task gait variability will be measured. | 24 weeks |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT01659073 -
Using Perfusion MRI to Measure the Dynamic Changes in Neural Activation Associated With Caloric Vestibular Stimulation
|
N/A | |
Recruiting |
NCT05914311 -
Use of Dermabond in Mitigation of Spinal Cord Stimulation (SCS) Trial Lead Migration
|
N/A | |
Recruiting |
NCT05422456 -
The Turkish Version of Functional Disability Inventory
|
||
Enrolling by invitation |
NCT05422443 -
The Turkish Version of Pain Coping Questionnaire
|
||
Completed |
NCT05057988 -
Virtual Empowered Relief for Chronic Pain
|
N/A | |
Completed |
NCT04385030 -
Neurostimulation and Mirror Therapy in Traumatic Brachial Plexus Injury
|
N/A | |
Recruiting |
NCT06206252 -
Can Medical Cannabis Affect Opioid Use?
|
||
Completed |
NCT05103319 -
Simultaneous Application of Ketamine and Lidocaine During an Ambulatory Infusion Therapy as a Treatment Option in Refractory Chronic Pain Conditions
|
||
Completed |
NCT03687762 -
Back on Track to Healthy Living Study
|
N/A | |
Completed |
NCT04171336 -
Animal-assisted Therapy for Children and Adolescents With Chronic Pain
|
N/A | |
Completed |
NCT03179475 -
Targin® for Chronic Pain Management in Patients With Spinal Cord Injury
|
Phase 4 | |
Completed |
NCT03418129 -
Neuromodulatory Treatments for Pain Management in TBI
|
N/A | |
Completed |
NCT03268551 -
MEMO-Medical Marijuana and Opioids Study
|
||
Recruiting |
NCT06204627 -
TDCS* and Laterality Trainnning in Patients With Chronic Neck Pain
|
N/A | |
Recruiting |
NCT06060028 -
The Power of Touch. Non-Invasive C-Tactile Stimulation for Chronic Osteoarthritis Pain
|
N/A | |
Completed |
NCT05496205 -
A SAD Study to Evaluate the Safety, Tolerability and PK/PD of iN1011-N17 in Healthy Volunteers
|
Phase 1 | |
Completed |
NCT00983385 -
Evaluation of Effectiveness and Tolerability of Tapentadol Hydrochloride in Subjects With Severe Chronic Low Back Pain Taking Either WHO Step I or Step II Analgesics or no Regular Analgesics
|
Phase 3 | |
Recruiting |
NCT05118204 -
Randomized Trial of Buprenorphine Microdose Inductions During Hospitalization
|
Phase 4 | |
Terminated |
NCT03538444 -
Repetitive Transcranial Magnetic Stimulation for Opiate Use Disorder
|
N/A | |
Not yet recruiting |
NCT05812703 -
Biometrics and Self-reported Health Changes in Adults Receiving Behavioral Treatments for Chronic Pain
|